甘李药业: 关于拟变更注册资本暨修订《公司章程》的公告

Core Viewpoint - 甘李药业 announced a change in its registered capital and a revision of its articles of association due to the repurchase and cancellation of certain restricted stocks that no longer meet incentive conditions [1][2][3] Summary by Sections Reason for Modification - The company will repurchase and cancel a total of 241,300 restricted stocks that have not met the incentive conditions, leading to a reduction in total share capital and registered capital [1][2] Changes in Registered Capital and Articles of Association - After the repurchase, the total share capital will decrease from 601,065,290 shares to 600,823,990 shares, and the registered capital will change from 601,065,290 yuan to 600,823,990 yuan [2] - The specific revisions to the articles of association include: - Article 6: Registered capital will be revised from 60,106.529 million yuan to 60,082.399 million yuan - Article 20: Total number of shares will be revised from 60,106.529 million shares to 60,082.399 million shares [2][3] Other Provisions - Other contents of the articles of association remain unchanged, and the changes will be finalized upon approval by the relevant market supervision authorities [3] - The company has followed the necessary procedures to notify creditors, who have the right to request debt repayment or guarantees within specified timeframes [3]